Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
advertisement
PharmTech
May 14, 2020
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

In this issue:

FDA Approves Novartis Lung Cancer Drug, Tabrecta

NJII Launches Cell and Gene Therapy
Manufacturing Center

EMA Commences Rolling Review of Remdesivir Data as COVID-19 Treatment


Top Stories

COVID-19 Update

Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /


FTC Clears AbbVie’s $63-Billion Acquisition of Allergan

AbbVie and Allergan have satisfied all required antitrust clearances for the acquisition.
/ read more /

 

Industry News

International Regulators Collaborate on
Regulatory Approaches During COVID-19

A high-level meeting on COVID-19 policies, organized by EMA under the auspice of the International Coalition of Medicines Regulatory Authorities (ICMRA), has brought together global regulators to ensure a coordinated pandemic response.
/ read more /


EMA Commences Rolling Review of Remdesivir Data as COVID-19 Treatment

A rolling review of data on the use of remdesivir, an investigational antiviral medicine, for the treatment of COVID-19 has been started by EMA’s Committee for Medicinal Products for Human Use.
/ read more /


More Industry News
advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe
 
 

advertisement
 
advertisement

Exclusive Interview from AAPS:
A Comprehensive Analysis Into Disintegration Mechanisms

/ View Now /

Sponsored by: JRS Pharma


Supplier News

Augury Adds Machine Health Monitoring Features

Remote, machine health monitoring services reduce the need for on-site visits.
/ read more /


NJII Launches Cell and Gene Therapy
Manufacturing Center

The center will be located at NJIT’s Life Sciences and Engineering center and will feature two good manufacturing practices suites that are expected to be completed and operational during the summer of 2020.
/ read more /


More Supplier News


 

Bio/Pharma News

Boehringer Ingelheim and Berg to Collaborate on Finding Biomarkers for Inflammatory Conditions

Boehringer Ingelheim will use the partnership to reveal novel insights into the complexities of various inflammatory diseases, which opens the potential for a clearer understanding of potential candidate biomarkers.
/ read more /


Ajinomoto Bio-Pharma Services, CytoDyn in
Manufacturing Partnership for COVID-19 Drug

The companies have entered into a manufacturing agreement to supply leronlimab, an investigational new drug currently being used in clinical trial protocols for COVID-19.
/ read more /


More Bio/Pharma News

 
 
 
 
 

Regulatory News

FDA Continues Fight Against Fraudulent COVID-19 Treatments

The agency is responding to companies promoting and selling medical products that claim, but are unproven, to prevent or treat COVID-19.
/ read more /


FDA Approves Novartis Lung Cancer Drug, Tabrecta

Tabrecta is approved to specifically target metastatic non-small cell lung cancer with a mutation that leads to MET exon 14 skipping (METex14).
/ read more /


More Regulatory News

 

Featured Topics

MANUFACTURING

Manufacturing Microneedle Array Patches for Vaccine Delivery

Equipment and process optimization must be considered for scaling up these developmental technologies to commercial production.
/ read more /


ANALYTICS

Contamination Drives a More Concerted
Approach to Genotoxins

Discovery of carcinogenic nitrosamines in three of the world’s most widely prescribed drugs is driving efforts to better detect, control and prevent their generation in APIs and finished drug products.
/ read more /

 
OUTSOURCING

Ensuring Smooth Tech Transfer of Bioprocesses to Outsourcing Partners

Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
/ read more /


QUALITY/REGULATIONS

Complying Confidently? Learning Lessons from Nitrosamine Impurities

Industry must never become complacent about the safety of drug products and should seek to continually perform surveillance even if the drug is well-established.
/ read more /

 
 
 

WEBCASTS

Through Container Verification of Pharmaceutical Raw Materials with the New Agilent Vaya Handheld Raman System
Europe Broadcast: Thursday, May 14, 2020 at 9am EDT | 2pm BST | 3pm CEST
US Broadcast: Thursday, May 14, 2020 at 2pm EDT | 1pm CDT | 11am PDT
Asia Pacific Broadcast: Friday, May 15, 2020 at 8:30am IST | 11am CST | 12pm JST | 1pm AEST
Learn More


Practical Considerations for Bringing Drug Candidates to Phase I Clinical Trial
Wednesday, May 27, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


Bulletproof your Supply Chain: Hope for the Best, Prepare for the Worst
Monday, May 18, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


Comprehensive Analysis into Disintegration Mechanisms: How Reliable Are Textbook Recommendations?
Wednesday, June 10, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


When Drug Meets Device: How to Assess Compatibility
Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More

 

Rescheduled Events

CPhI South East Asia

CPhI South East Asia has been rescheduled for July 2020.

Interphex 2020

Interphex 2020 has been rescheduled for July 2020.

69th PDA Annual Meeting

PDA’s Annual Meeting has been rescheduled for July 2020.

Bioprocessing Summit Europe

Bioprocessing Summit Europe has been rescheduled for July 2020.

PDA Pharmaceutical Manufacturing Data Science Workshop

PDA’s Pharmaceutical Manufacturing Data Science Workshop has been rescheduled for July 2020.

Validation University

Validation University has been rescheduled for August 2020.

CPhI North America

CPhI North America has been rescheduled for September 2020.

CPhI Japan

CPhI Japan has been rescheduled for September 2020

Analytica 2020

Analytica 2020 has been rescheduled for October 2020.

Interpack 2020

Interpack 2020 has been rescheduled for February 2021.

more events

eBOOKS

Regulatory Sourcebook and Reference, March 2020

The Pharmacopoeia Compliance Series features a description of ways bio/pharma companies can participate in monograph development, a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.


contribute | contact editors | CONTACT SALES | subscribe | advertise